Investigation of the activity of vidofludimus calcium, a novel, orally available, small molecule inhibitor of dihydroorotate dehydrogenase, as a treatment for primary sclerosing cholangitis (PSC)

Mayo Clinic Arizona, Scottsdale AZ

Investigators

Linked publications & trials